Retrospective analysis of hyper-fractionated radiotherapy for LD-SCLC

Retrospective analysis of hyper-fractionated radiotherapy for LD-SCLC - Restrospective analysis of HFRT for LD-SCLC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040548

Enrollment

Registered

2020-05-31

Start date

2015-11-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small cell lung carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Diagnosed as limited disease of small cell lung carcinoma. 2) Case of chemo-radiotherapy using hyper-fractionated radiotherapy.

Exclusion criteria

Exclusion criteria: Case of radiotherapy for recurrence.

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Secondary

Measure	Time frame
Local control Late toxicity	—

Countries

Japan

Contacts

Public ContactYasuhito Hagiwara

Faculty of Medicine, Yamagata University Division of Radiation Oncology

hagiwara.yasuhito@gmail.com+81-23-628-5386

Outcome results